動物用ワクチンの市場規模、シェア、動向分析レポート：動物タイプ別、製品タイプ別、投与経路別、流通チャネル別、地域別、セグメント別予測、2025年～2030年

動物用ワクチン市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の動物用ワクチン市場規模は2030年までに229億5,000万米ドルに達する見込みです。

同市場は、2025～2030年にかけてCAGR 9.5％で拡大すると予測されています。食品を媒介とする人獣共通感染症の増加や畜産業の増加がワクチン需要を押し上げています。無脊椎動物における鳥インフルエンザや結核のような特定の伝染性疾患は、直接または間接的にヒトに感染する可能性があります。消費者が加熱不十分な魚を介してミミズを食べると、線虫のいくつかの種によって引き起こされる人獣共通感染症であるアニサキス症に汚染される可能性があります。

反芻動物、特に牛のワクチンが世界的に広く受け入れられている主要要因は、牛の疾病発生の増加と増え続ける家畜頭数です。さらに、ペット飼育の増加とコンパニオンアニマルの健康に関する意識の高まりが、市場の成長を後押ししています。さらに、企業による研究開発投資の増加も主要な成長要因の一つです。予測期間中、市場の競合は激しくなると予想されます。同市場は、大小さまざまな参入企業が存在するため、非常に細分化されています。このため、市場内での地位を維持しようとする小規模参入企業間の競争が激しくなっています。

さらに、企業は市場で成長するために、M&A、地理的拡大、新製品の発売などの戦略を採用する傾向が強まっています。例えば、2020年12月、ElancoはKindred BiosciencesからKIND-030と呼ばれる犬パルボウイルス（CPV）用モノクローナル抗体の独占的世界販売権を取得しました。これにより、同社のワクチンと治療ポートフォリオ全体が強化されました。さらに2020年9月、セバはフランスの施設で細菌性自家ワクチンの生産能力を増強しました。これは同社の成長戦略を支えるものと期待されます。

動物用ワクチン市場レポートハイライト

• 弱毒生ワクチンセグメントが市場を独占し、2024年には37.00%以上の売上シェアを占めます。
• 畜産セグメントが市場を独占し、2024年の収益シェアが最も高かったです。これは、家畜人口の増加、政府の支援策、牛や羊の疾病発生などの要因によるものです。
• 病院/クリニック薬局は、2024年に市場で圧倒的なシェアを占めました。これらの施設は、新技術の採用において最前線に立つことが多いです。
• 2024年の動物用ワクチンの売上シェアは皮下投与型が41.0%を超え、市場を独占しました。
• 北米が市場を独占し、2024年の売上シェアは28%を超えました。同地域は予測期間を通じて優位を保つと予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 動物用ワクチン市場の変動動向と展望

• 市場系統の展望
  • 親市場
  • 補助市場
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 動物用ワクチン市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析
  • 規制の枠組み
  • 価格分析
  • 疾患有病率分析
  • 主要国別、主要種による動物推定個体数（2024年）
  • COVID-19の影響分析

第4章 動物用ワクチン市場：動物タイプ別、推定・動向分析

• セグメントダッシュボード
• 動物用ワクチン市場：動物タイプ変動分析
• 動物用ワクチン市場規模と動向分析（動物タイプ別、2018～2030年）
• 家畜
  • 家禽
  • 水産
  • 反芻動物
  • 豚
• 仲間
  • 犬歯
  • ネコ科
  • その他

第5章 動物用ワクチン市場：製品別、推定・動向分析

• セグメントダッシュボード
• 動物用ワクチン市場：製品変動分析
• 動物用ワクチン市場規模と動向分析（製品別、2018～2030年）
  • 弱毒生ワクチン
  • 不活化ワクチン
  • サブユニットワクチン
  • DNAワクチン
  • 組み換えワクチン

第6章 動物用ワクチン市場：投与経路別、推定・動向分析

• セグメントダッシュボード
• 動物用ワクチン市場：投与経路別変動分析
• 動物用ワクチン市場規模と動向分析（投与経路別、2018～2030年）
  • 皮下
  • 筋肉内
  • 鼻腔内

第7章 動物用ワクチン市場：流通チャネル別、推定・動向分析

• セグメントダッシュボード
• 動物用ワクチン市場：流通チャネル変動分析
• 動物用ワクチン市場規模と動向分析（流通チャネル別、2018～2030年）
  • 小売
  • eコマース
  • 病院/クリニック薬局

第8章 動物用ワクチン市場：地域別、推定・動向分析

• 地域ダッシュボード
• 動物用ワクチン市場シェア（地域別、2024年と2030年）、100万米ドル
• 地域展望
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 市場参入企業の分類
• 企業の市況分析/ヒープマップ分析
• 企業プロファイル
  • Merck & Co., Inc.
  • Zoetis
  • Virbac
  • Elanco
  • Boehringer Ingelheim Animal Health
  • Phibro Animal Health Corporation
  • Calier
  • Ceva
  • Bimeda Biologicals
  • Neogen Corporation
• 戦略マッピング
  • 合併と買収
  • パートナーシップとコラボレーション
  • 拡大
  • 製品発売
  • 製品承認
  • その他
• その他の主要人物一覧

List of Tables

• Table 1 List of secondary sources
• Table 2 Animal Vaccines Market, by region, 2018 - 2030 (USD Million)
• Table 3 Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 4 Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 5 Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 6 Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 7 North America Animal Vaccines Market, by country, 2018 - 2030 (USD Million)
• Table 8 North America Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 9 North America Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 10 North America Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 11 North America Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 12 U.S. Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 13 U.S. Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 14 U.S. Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 15 U.S. Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 16 Canada Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 17 Canada Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 18 Canada Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 19 Canada Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 20 Mexico Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 21 Mexico Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 22 Mexico Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 23 Mexico Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 24 Europe Animal Vaccines Market, by country, 2018 - 2030 (USD Million)
• Table 25 Europe Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 26 Europe Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 27 Europe Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 28 Europe Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 29 Germany Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 30 Germany Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 31 Germany Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 32 Germany Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 33 UK Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 34 UK Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 35 UK Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 36 UK Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 37 France Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 38 France Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 39 France Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 40 France Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 41 Italy Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 42 Italy Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 43 Italy Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 44 Italy Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 45 Spain Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 46 Spain Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 47 Spain Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 48 Spain Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 49 Denmark Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 50 Denmark Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 51 Denmark Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 52 Denmark Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 53 Sweden Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 54 Sweden Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 55 Sweden Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 56 Sweden Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 57 Norway Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 58 Norway Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 59 Norway Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 60 Norway Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific Animal Vaccines Market, by country, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 66 China Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 67 China Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 68 China Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 69 China Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 70 Japan Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 71 Japan Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 72 Japan Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 73 Japan Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 74 India Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 75 India Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 76 India Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 77 India Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 78 South Korea Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 79 South Korea Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 80 South Korea Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 81 South Korea Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 82 Australia Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 83 Australia Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 84 Australia Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 85 Australia Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 86 Thailand Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 87 Thailand Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 88 Thailand Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 89 Thailand Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 90 Latin America Animal Vaccines Market, by country, 2018 - 2030 (USD Million)
• Table 91 Latin America Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 92 Latin America Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 93 Latin America Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 94 Latin America Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 95 Brazil Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 96 Brazil Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 97 Brazil Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 98 Brazil Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 99 Argentina Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 100 Argentina Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 101 Argentina Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 102 Argentina Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 103 MEA Animal Vaccines Market, by country, 2018 - 2030 (USD Million)
• Table 104 MEA Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 105 MEA Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 106 MEA Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 107 MEA Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 108 South Africa Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 109 South Africa Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 110 South Africa Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 111 South Africa Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 116 UAE Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 117 UAE Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 118 UAE Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 119 UAE Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 120 Kuwait Animal Vaccines Market, by Animal type, 2018 - 2030 (USD Million)
• Table 121 Kuwait Animal Vaccines Market, by Route of administration, 2018 - 2030 (USD Million)
• Table 122 Kuwait Animal Vaccines Market, by Product, 2018 - 2030 (USD Million)
• Table 123 Kuwait Animal Vaccines Market, by Distribution channel, 2018 - 2030 (USD Million)
• Table 124 Company Overview
• Table 125 Product Benchmarking
• Table 126 Financial Performance
• Table 127 Strategic Initiatives

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Animal Vaccines Market revenue, 2018 - 2030 (USD Million)
• Fig. 10 Animal Vaccines Market snapshot
• Fig. 11 Animal Vaccines Market driver impact
• Fig. 12 Animal Vaccines Market restraint impact
• Fig. 13 Animal Vaccines animal type key takeaways (USD Million)
• Fig. 14 Animal Vaccines Market: animal Type movement analysis
• Fig. 15 Companion market, 2018 - 2030 (USD Million)
• Fig. 16 canine market, 2018 - 2030 (USD Million)
• Fig. 17 Feline market, 2018 - 2030 (USD Million)
• Fig. 18 Others market, 2018 - 2030 (USD Million)
• Fig. 19 Livestock market, 2018 - 2030 (USD Million)
• Fig. 20 poultry market, 2018 - 2030 (USD Million)
• Fig. 21 aqua market, 2018 - 2030 (USD Million)
• Fig. 22 ruminant market, 2018 - 2030 (USD Million)
• Fig. 23 Swine market, 2018 - 2030 (USD Million)
• Fig. 24 Animal Vaccines Market Product key takeaways (USD Million)
• Fig. 25 Animal Vaccines Market: product movement analysis
• Fig. 26 Attenuated live vaccines market, 2018 - 2030 (USD Million)
• Fig. 27 Inactivated vaccines market, 2018 - 2030 (USD Million)
• Fig. 28 Subunit Vaccines market, 2018 - 2030 (USD Million)
• Fig. 29 DNA vaccines market, 2018 - 2030 (USD Million)
• Fig. 30 Recombinant Vaccines market, 2018 - 2030 (USD Million)
• Fig. 31 Animal Vaccines Market route of administration key takeaways (USD Million)
• Fig. 32 Animal Vaccines Market: route of administration movement analysis
• Fig. 33 Subcutaneous vaccines market, 2018 - 2030 (USD Million)
• Fig. 34 Intramuscular vaccines market, 2018 - 2030 (USD Million)
• Fig. 35 Intranasal Vaccines market, 2018 - 2030 (USD Million)
• Fig. 36 Animal Vaccines Market by distribution channel key takeaways (USD Million)
• Fig. 37 Animal Vaccines Market: by distribution channel movement analysis
• Fig. 38 hospitals/clinic pharmacy market, 2018 - 2030 (USD Million)
• Fig. 39 Retail pharmacy market, 2018 - 2030 (USD Million)
• Fig. 40 E-Commerce market, 2018 - 2030 (USD Million)
• Fig. 41 Regional market place: Key takeaways
• Fig. 42 Regional outlook, 2024 & 2030
• Fig. 43 North America Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 44 U.S. Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 45 Canada Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 46 Mexico Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 47 Europe Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 48 UK Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 49 Germany Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 50 France Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 51 Italy Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 52 Spain animal vaccines market, 2018 - 2030 (USD Million)
• Fig. 53 Denmark Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 54 Sweden Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 55 Norway Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 56 Asia Pacific Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 57 Japan Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 58 China Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 59 India Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 60 Australia Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 61 South Korea Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 62 Thailand Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 63 Latin America Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 64 Brazil Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 65 Argentina Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 66 MEA Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 67 South Africa Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 68 Saudi Arabia Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 69 UAE Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 70 Kuwait Animal Vaccines Market, 2018 - 2030 (USD Million)
• Fig. 71 Market participant categorization

Animal Vaccines Market Growth & Trends:

The global animal vaccines market size is expected to reach USD 22.95 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 9.5% from 2025 to 2030. The growing incidence of food-borne zoonotic diseases and increasing animal husbandry are boosting the demand for vaccines. Certain transmissible diseases such as bird flu and tuberculosis in invertebrate animals can be transferred directly or indirectly to humans. If consumers eat worms via undercooked fish, they can get contaminated with anisakiasis, a human zoonotic infection caused by some species of nematodes.

The increasing outbreaks of cattle disease and the ever-expanding livestock population are the prime factors for the wide acceptance of the ruminants especially cattle vaccines globally. Moreover, rising pet ownership and increasing awareness regarding the health of companion animals are propelling the market growth. Moreover, the increasing number of R&D investments initiated by the companies is one of the key growth factors. Competition in the market is expected to be high during the forecast period. The market is highly fragmented owing to the presence of several small and large players. This results in high competition among small players to sustain their position in the market.

Moreover, companies are increasingly adopting strategies, such as mergers & acquisitions, geographic expansion, and the launch of new products, to grow in the market. For instance, in December 2020, Elanco acquired exclusive global rights from Kindred Biosciences to its monoclonal antibody for Canine Parvovirus (CPV) called KIND-030. This strengthened the company's overall vaccine and therapeutics portfolios. Moreover, in September 2020, Ceva enhanced its production capacity at its French facility for bacterial autogenous vaccines. This is expected to support its growth strategy.

Animal Vaccines Market Report Highlights:

• The attenuated live vaccines segment dominated the market and accounted for a revenue share of over 37.00% in 2024.
• The livestock segment dominated the market with the highest revenue share in 2024. This can be attributed to factors such as the rising livestock population, supportive government initiatives, and the outbreak of diseases among cattle and sheep.
• Hospital/clinic pharmacy held the dominant share of the market in 2024. These facilities are often at the forefront of adopting new technologies.
• The subcutaneous segment dominated the market for animal vaccines, with a revenue share of over 41.0% in 2024.
• North America dominated the market and accounted for a revenue share of over 28% in 2024. The region is expected to remain dominant throughout the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Animal Vaccines Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising livestock population
    • 3.2.1.2. Increasing disease outbreak
    • 3.2.1.3. Rising R&D and manufacturing advancements
    • 3.2.1.4. Growing demand for animal derived food products
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of awareness
    • 3.2.2.2. Complex regulations
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Animal Vaccines Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Pricing Analysis
  • 3.3.5. Disease Prevalence Analysis
  • 3.3.6. Estimated Animal Population by key countries, key species, 2024
  • 3.3.7. COVID-19 Impact Analysis

Chapter 4. Animal Vaccines Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Animal Vaccines Market: Animal type Movement Analysis
• 4.3. Animal Vaccines Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
• 4.4. Livestock
  • 4.4.1. Livestock Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.2. Poultry
    • 4.4.2.1. Poultry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.3. Aqua
    • 4.4.3.1. Aqua Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.4. Ruminant
    • 4.4.4.1. Ruminant Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4.5. Swine
    • 4.4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.5. Companion
  • 4.5.1. Companion Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.2. Canine
    • 4.5.2.1. Canine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.3. Feline
    • 4.5.3.1. Feline Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5.4. Others
    • 4.5.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Animal Vaccines Market: By Product Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Animal Vaccines Market: By Product Movement Analysis
• 5.3. Animal Vaccines Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
  • 5.3.1. Attenuated Live Vaccines
    • 5.3.1.1. Attenuated Live Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.2. Inactivated Vaccines
    • 5.3.2.1. Inactivated Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.3. Subunit Vaccines
    • 5.3.3.1. Subunit Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.4. DNA Vaccines
    • 5.3.4.1. DNA Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.3.5. Recombinant Vaccines
    • 5.3.5.1. Recombinant Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Animal Vaccines Market: By Route of Administration Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Animal Vaccines Market: By Route of Administration Movement Analysis
• 6.3. Animal Vaccines Market Size & Trend Analysis, by route of administration, 2018 to 2030 (USD Million)
  • 6.3.1. Subcutaneous
    • 6.3.1.1. Subcutaneous Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.2. Intramuscular
    • 6.3.2.1. Intramuscular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3.3. Intranasal
    • 6.3.3.1. Intranasal Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Animal Vaccines Market: By Distribution Channel Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Animal Vaccines Market: By Distribution Channel Movement Analysis
• 7.3. Animal Vaccines Market Size & Trend Analysis, by distribution channel, 2018 to 2030 (USD Million)
  • 7.3.1. Retail
    • 7.3.1.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. E-Commerce
    • 7.3.2.1. E-Commerce Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Hospital/Clinic Pharmacy
    • 7.3.3.1. Hospital/Clinic Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Animal Vaccines Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Animal Vaccines Market Share, By Region, 2024 & 2030, USD Million
• 8.3. Regional Outlook
• 8.4. North America
  • 8.4.1. North America Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. U.S. Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Canada Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Mexico Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. UK Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Germany Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. France Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Italy Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Spain Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Denmark Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Sweden Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Norway Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Japan Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. China Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. India Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Australia Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. South Korea Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Thailand Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Brazil Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Argentina Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. South Africa Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Saudi Arabia Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. UAE Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Kuwait Animal Vaccines Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Company Market Position Analysis/ Heap Map Analysis
• 9.3. Company Profiles
  • 9.3.1. Merck & Co., Inc.
    • 9.3.1.1. Participant's Overview
    • 9.3.1.2. Financial Performance
    • 9.3.1.3. Product Benchmarking
    • 9.3.1.4. Strategic Initiatives
  • 9.3.2. Zoetis
    • 9.3.2.1. Participant's Overview
    • 9.3.2.2. Financial Performance
    • 9.3.2.3. Product Benchmarking
    • 9.3.2.4. Strategic Initiatives
  • 9.3.3. Virbac
    • 9.3.3.1. Participant's Overview
    • 9.3.3.2. Financial Performance
    • 9.3.3.3. Product Benchmarking
    • 9.3.3.4. Strategic Initiatives
  • 9.3.4. Elanco
    • 9.3.4.1. Participant's Overview
    • 9.3.4.2. Financial Performance
    • 9.3.4.3. Product Benchmarking
    • 9.3.4.4. Strategic Initiatives
  • 9.3.5. Boehringer Ingelheim Animal Health
    • 9.3.5.1. Participant's Overview
    • 9.3.5.2. Financial Performance
    • 9.3.5.3. Product Benchmarking
    • 9.3.5.4. Strategic Initiatives
  • 9.3.6. Phibro Animal Health Corporation
    • 9.3.6.1. Participant's Overview
    • 9.3.6.2. Financial Performance
    • 9.3.6.3. Product Benchmarking
    • 9.3.6.4. Strategic Initiatives
  • 9.3.7. Calier
    • 9.3.7.1. Participant's Overview
    • 9.3.7.2. Financial Performance
    • 9.3.7.3. Product Benchmarking
    • 9.3.7.4. Strategic Initiatives
  • 9.3.8. Ceva
    • 9.3.8.1. Participant's Overview
    • 9.3.8.2. Financial Performance
    • 9.3.8.3. Product Benchmarking
    • 9.3.8.4. Strategic Initiatives
  • 9.3.9. Bimeda Biologicals
    • 9.3.9.1. Participant's Overview
    • 9.3.9.2. Financial Performance
    • 9.3.9.3. Product Benchmarking
    • 9.3.9.4. Strategic Initiatives
  • 9.3.10. Neogen Corporation
    • 9.3.10.1. Participant's Overview
    • 9.3.10.2. Financial Performance
    • 9.3.10.3. Product Benchmarking
    • 9.3.10.4. Strategic Initiatives
• 9.4. Strategy Mapping
  • 9.4.1. Mergers & Acquisitions
  • 9.4.2. Partnerships & Collaborations
  • 9.4.3. Expansion
  • 9.4.4. Product launch
  • 9.4.5. Product Approval
  • 9.4.6. Others
• 9.5. List of other key players